Institutional Ownership
Arbutus Biopharma Corp
CUSIP 03879J100COMABUSQ1 2026
Institutional Holders
160
13F filers
Shares Held
129.64M
Aggregate institutional
Institutional Value
$582.50M
Q1 2026
Net New Holders
-9
23 new · 32 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions23
Increased48
Decreased47
Sold out32
Institutional Holders
160 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Morgan Stanley | 25.89M | $116.51M | −811.3K | Reduced |
| 2 | Two Seas Capital LP | 18.56M | $83.51M | +5.97M | Added |
| 3 | Whitefort Capital Management, LP | 14.93M | $67.19M | +1.59M | Added |
| 4 | Blackrock, Inc. | 12.97M | $58.35M | −85.9K | Reduced |
| 5 | Rubric Capital Management LP | 6.63M | $29.82M | +5.05M | Added |
| 6 | State Street Corp | 6.34M | $28.54M | +434.3K | Added |
| 7 | Barclays PLC | 4.32M | $19.42M | +3.96M | Added |
| 8 | Geode Capital Management, LLC | 3.77M | $16.98M | +94.5K | Added |
| 9 | Adar1 Capital Management, LLC | 3.13M | $14.10M | −2.28M | Reduced |
| 10 | Adage Capital Partners Gp, L.L.C. | 2.66M | $11.99M | −1.68M | Reduced |
150 more institutional holders on Premium
See every fund holding Arbutus Biopharma Corp, with full quarter-over-quarter share changes.
Unlock all holders